Open AccessImpact ofKRASmutation and PTEN expression on cetuximab-treated colorectal cancer
Author(s) -
Fang Hua Li,
Lin Shen,
Zhuang Hua Li,
Hui Luo,
Miao Zhen Qiu,
Hui Zhong Zhang,
Yu Hong Li,
RuiHua Xu
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i46.5881
Subject(s) - pten , cetuximab , kras , colorectal cancer , medicine , tensin , oncology , cancer research , cancer , regimen , immunohistochemistry , biology , pi3k/akt/mtor pathway , apoptosis , biochemistry
To investigate the prognostic value of KRAS mutation, and phosphatase and tensin (PTEN) expression in Chinese metastatic colorectal cancer metastatic colorectal cancer (mCRC) patients treated with cetuximab.